Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vigilance regulation as predictor of methylphenidate response in adults with ADHD
2015-000488-15Phase 4Completed
- Sponsor
- Leipzig University
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Leipzig University. Primary endpoint: Relationship between baseline vigilance regulation and treatment success. Started Aug 2015; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2015-000488-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000488-15.